Becker JC - Search Results

1

Eradication of established hepatic human neuroblastoma metastases in mice with severe combined immunodeficiency by antibody-targeted interleukin-2.

Pancook JD, Becker JC, Gillies SD, Reisfeld RA. Pancook JD, et al. Among authors: becker jc. Cancer Immunol Immunother. 1996 Feb;42(2):88-92. doi: 10.1007/s002620050256. Cancer Immunol Immunother. 1996. PMID: 8620525 Free PMC article.

2

Eradication of human hepatic and pulmonary melanoma metastases in SCID mice by antibody-interleukin 2 fusion proteins.

Becker JC, Pancook JD, Gillies SD, Mendelsohn J, Reisfeld RA. Becker JC, et al. Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2702-7. doi: 10.1073/pnas.93.7.2702. Proc Natl Acad Sci U S A. 1996. PMID: 8610104 Free PMC article.

3

Involvement of B lymphocytes in the growth inhibition of human pulmonary melanoma metastases in athymic nu/nu mice by an antibody-lymphotoxin fusion protein.

Reisfeld RA, Gillies SD, Mendelsohn J, Varki NM, Becker JC. Reisfeld RA, et al. Among authors: becker jc. Cancer Res. 1996 Apr 15;56(8):1707-12. Cancer Res. 1996. PMID: 8620479

4

T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy.

Becker JC, Pancook JD, Gillies SD, Furukawa K, Reisfeld RA. Becker JC, et al. J Exp Med. 1996 May 1;183(5):2361-6. doi: 10.1084/jem.183.5.2361. J Exp Med. 1996. PMID: 8642346 Free PMC article.

5

An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response.

Becker JC, Varki N, Gillies SD, Furukawa K, Reisfeld RA. Becker JC, et al. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7826-31. doi: 10.1073/pnas.93.15.7826. Proc Natl Acad Sci U S A. 1996. PMID: 8755561 Free PMC article.

6

Long-lived and transferable tumor immunity in mice after targeted interleukin-2 therapy.

Becker JC, Varki N, Gillies SD, Furukawa K, Reisfeld RA. Becker JC, et al. J Clin Invest. 1996 Dec 15;98(12):2801-4. doi: 10.1172/JCI119107. J Clin Invest. 1996. PMID: 8981927 Free PMC article.

7

Immunocytokines: a promising approach to cancer immunotherapy.

Lode HN, Xiang R, Becker JC, Gillies SD, Reisfeld RA. Lode HN, et al. Among authors: becker jc. Pharmacol Ther. 1998 Dec;80(3):277-92. doi: 10.1016/s0163-7258(98)00033-3. Pharmacol Ther. 1998. PMID: 9888698 Review.

8

Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3.

Montgomery AM, Becker JC, Siu CH, Lemmon VP, Cheresh DA, Pancook JD, Zhao X, Reisfeld RA. Montgomery AM, et al. Among authors: becker jc. J Cell Biol. 1996 Feb;132(3):475-85. doi: 10.1083/jcb.132.3.475. J Cell Biol. 1996. PMID: 8636223 Free PMC article.

9

Lymphocyte-mediated alopecia in C57BL/6 mice following successful immunotherapy for melanoma.

Becker JC, Varki N, Bröcker EB, Reisfeld RA. Becker JC, et al. J Invest Dermatol. 1996 Oct;107(4):627-32. doi: 10.1111/1523-1747.ep12584237. J Invest Dermatol. 1996. PMID: 8823372 Free article.

10

Immunocytokines: a new approach to immunotherapy of melanoma.

Reisfeld RA, Becker JC, Gillies SD. Reisfeld RA, et al. Among authors: becker jc. Melanoma Res. 1997 Aug;7 Suppl 2:S99-106. Melanoma Res. 1997. PMID: 9578424 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

660 results

Search Page

Filters